Profile

From: WHO, 2013. World Malaria Report 2012. Geneva: World Health Organization. Available at: www.who.int

Epidemiological profile of Nigeria

Population by malaria endemicity (000) 2011 %
High transmission (≥ 1 case per 1000 population) 162 000 100
Low transmission (0-1 cases per 1000 population) 0 0
Malaria free (0 cases) 0 0
Total 162 000  
Parasites and vectors
Major plasmodium species P. falciparum (100%), P. vivax (0%)
Major anopheles species An. gambiae, arabiensis, funestus, moucheti, melas, nili 

Intervention policies and strategies

   Intervention    WHO-recommended policy/strategy Yes/no Year adopted
ITN/LLIN

ITNs/LLINs distributed free of charge

ITNs/LLINs distributed to all age groups

Yes

Yes

2001

2009

IRS

IRS is recommended

DDT is used for IRS

Yes

No

2007

-

IPT IPT is used to prevent malaria during pregnancy Yes 2004
Case management

Patients of all ages should receive diagnostic test

RDTs used at community level

ACT is free for all ages in public sector

Pre-referral treatment with recommended medicines

Marketing authorization for all oral artemisinin-based monotherapies withdrawn

Yes

No

Yes

Yes

Yes

2006

-

2009

2006

2009

 

Antimalarial policy Type of medicine Year adopted
First-line treatment of unconfirmed malaria AL; AS+AQ 2004
First-line treatment of P.falciparum AL; AS+AQ 2004
For treatment failure of P.falciparum QN 2004
Treatment of severe malaria AM; AS; QN 2004
Treatment of P.vivax - -

Therapeutic efficacity tests (therapeutic or parasitological failure, %)

Medicine Year No. of studies Min. Median Max. Follow-up
AL 2002-2007 5 0 0 2 28 days
AS+AQ 2004-2006 5 0 0 7.8 28 days